HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antiinflammatory and antifibrotic properties of colchicine: implications for idiopathic pulmonary fibrosis.

Abstract
The ancient drug colchicine has repeatedly been proposed as a novel drug for therapy of pulmonary fibrosis. The present study was undertaken to add to the knowledge on colchicine's antiinflammatory and antifibrotic properties and thus help determine its actual rank in the treatment of pulmonary fibrosis. In vitro cell culture experiments with stimulated and unstimulated normal donor peripheral blood mononuclear cells (PMNC) and a human lung fibroblast cell line (WI-38) were used to determine the effects of colchicine on PMNC cytokine release (interleukin-6 and tumor necrosis factor-alpha) as well as on fibroblast proliferation and collagen synthesis rates. Reverse transcriptase polymerase chain amplifications of alpha 1 (III) collagen were done to detect collagen messenger ribonucleic acid (mRNA) expression. Colchicine did not significantly modulate tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) release of PMNC. Colchicine inhibited fibroblast proliferation and total collagen synthesis significantly at concentrations obtainable in serum in vivo. Transcription of the alpha 1 (III) collagen gene into mRNA continued under colchicine. We conclude that colchicine is a potent in vitro inhibitor of fibroblast functions in terms of proliferation and collagen synthesis. The mechanism of collagen inhibition is more likely an inhibition of cellular collagen secretion than a switch off of collagen mRNA transcription. On the other hand, although colchicine is known to inhibit many leukocyte functions, it is a poor inhibitor of cytokines known to be important for fibrogenesis (e.g. IL-6, TNF-alpha, IL-1, platelet-derived growth factor, and transforming growth factor-beta). This makes colchicine, at least from a theoretical standpoint and as concluded from in vitro studies, a preferable candidate for a combined therapeutic strategy.
AuthorsP Entzian, M Schlaak, U Seitzer, A Bufe, Y Acil, P Zabel
JournalLung (Lung) Vol. 175 Issue 1 Pg. 41-51 ( 1997) ISSN: 0341-2040 [Print] United States
PMID8959672 (Publication Type: Journal Article)
Chemical References
  • Interleukin-6
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Collagen
  • Colchicine
Topics
  • Cells, Cultured
  • Colchicine (pharmacology, therapeutic use)
  • Collagen (biosynthesis, genetics)
  • Fibroblasts (drug effects, physiology)
  • Humans
  • Interleukin-6 (metabolism)
  • Leukocytes, Mononuclear (drug effects, immunology)
  • Pulmonary Fibrosis (drug therapy)
  • RNA, Messenger (analysis)
  • Statistics, Nonparametric
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: